147
Participants
Start Date
July 31, 2015
Primary Completion Date
May 31, 2019
Study Completion Date
May 31, 2019
Sevuparin
The Drug Product sevuparin solution for IV infusion
Placebo
Placebo for IV infusion
Salmaniya Hospital, Kingdom of Bahrain, Manama
Salmaniya Medical Complex, Bahrain, Manama
Annotto Bay Hospital, Annotto Bay
Kingston Public Hospital, Kingston
University Hospital of the West Indies, Kingston
Winchester Surgical and Medical Institute, Kingston
Mandeville Regional Hospital, Mandeville
May Pen Public Hospital Clarendon, May Pen
Cornwall Regional Hospital, Jamaica, Montego Bay
American University of Beirut Medical Center, Beirut, Cairo street, Beirut, Lebanon, Beirut
Nini Hospital, Tripoli
Dept of Haematology, Amsterdam
Erasmus MC, Rotterdam
Sultan Qaboos University Hospital Alkhodh, Oman, Muscat
Sultan Qaboos University, Muscat
King Fahd Medical City, As Sulimaniyah, Riyadh Saudiarabien, Riyadh
King Saud University, Riyadh, Saudiarabien, Riyadh
Mersin University Faculty of Medicine, Adana
Cukurova University Faculty Of Medicine Tıp Fakültesi, Adana
Dr Antmen, Adana
Lead Sponsor
Collaborators (1)
Ergomed
INDUSTRY
Modus Therapeutics AB
INDUSTRY